Results for tag: "HER2 Lung Cancer Drugs"

The HER2 Lung Cancer Drugs market is a subset of the larger Lung Cancer Drugs market. HER2 Lung Cancer Drugs are a type of targeted therapy used to treat non-small cell lung cancer (NSCLC) that is HER2-positive. These drugs work by blocking the HER2 protein, which is found in higher levels in some NSCLC tumors. HER2 Lung Cancer Drugs are used in combination with other treatments, such as chemotherapy, radiation, and immunotherapy. They are typically used in the later stages of NSCLC, when the cancer has spread to other parts of the body. Some of the companies in the HER2 Lung Cancer Drugs market include AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Merck, and Roche. Show Less Read more